<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01594658</url>
  </required_header>
  <id_info>
    <org_study_id>VUT-3F</org_study_id>
    <nct_id>NCT01594658</nct_id>
  </id_info>
  <brief_title>Venous Ulcer Treatment With Foam Versus Conservative Treatment</brief_title>
  <acronym>VUTEF</acronym>
  <official_title>Prospective Random Study for Handling Venous Ulcer With Conservative Treatment (Dressings Alone) and Foam Sclerotherapy Versus Conservative Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Occidente de Kennedy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Universidad El Bosque, Bogotá</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Occidente de Kennedy</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The venous ulcer due to venous insufficiency causes an important morbility to those people
      suffering from this condition. Most of therapies available under the obligatory health plan
      (POS, acronym in spanish) to date cover the cleaning of the ulcerous lesion and its medical
      handling using saline solutions, topical antibiotics and elastic dressings, implying an
      important intake from health resources due to its chronicity and the delay in ulcers healing,
      which usually takes periods ranging from 6 months to several years. therapeutical
      alternatives, which can guarantee optimal, fast and persistent in time healings, should be
      identified.

      The aim of this study is to determine the percentage of healing of active venous ulcers
      (using a clinical, etiological, anatomic and physiopathologic classification (CEAP), C6)
      following ultrasound-guided foam sclerotherapy of superficial venous reflux in patients with
      chronic venous ulceration after six months from the intervention, compared with conservative
      medical handling. The investigators expect that the ultrasound-guided foam sclerotherapy of
      superficial venous reflux will diminish the time of ulcer healing compared with standard
      handling.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      to determine healing rates following ultrasound-guided foam sclerotherapy (UGFS) of
      superficial venous reflux (SVR) in patients with open (clinical,etiologic, anatomic and
      pathophysiologic (CEAP) classification, C6) chronic venous ulceration ( CVU) in a randomised
      clinical trial of foam sclerotherapy for patients with venous ulcer
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2011</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Venous Ulcer Treatment with Foam Versus Conservative Treatment</measure>
    <time_frame>6 months</time_frame>
    <description>Number of participants with healing of venous ulcer after six months from the intervention.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">46</enrollment>
  <condition>Venous Ulcer</condition>
  <arm_group>
    <arm_group_label>Foam sclerotherapy</arm_group_label>
    <description>This arm corresponds to ultrasound-guided foam sclerotherapy of superficial venous reflux plus conservative management</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conservative</arm_group_label>
    <description>This arm only has medical standard handling (healings performed by the nurse group)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Foam sclerotherapy</intervention_name>
    <description>Foam application of 1% (Sklerol®, ICV Pharma, Bogota-Colombia), Reg INVIMA: 2002M-0001016, guided by ecography of insufficient superficial veins, doses from 10-40 cc of foam until obtaining endoluminal occlusion of the vein. The patient will rest for 8 minutes and then the leg will be covered with elastic bandage.</description>
    <arm_group_label>Foam sclerotherapy</arm_group_label>
    <other_name>(Sklerol®, ICV Pharma, Bogota-Col),Reg INVIMA: 2002M-0001016</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>conservative</intervention_name>
    <description>This arm only has medical standard handling (healings performed by the nurse group)</description>
    <arm_group_label>Conservative</arm_group_label>
    <other_name>This arm only has medical standard handling</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with C6 by CEAP Clasification
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Presence of Venous Ulcer confirmed by CEAP C6

          -  Chronic venous ulcer present for at least 4 weeks

          -  Ankle-arm index greater or equal to 0.8 mmHg

        Exclusion Criteria:

          -  Severe hepatic, cardiac or pulmonary disease

          -  Deep venous thrombosis

          -  Active participation in other clinical trials
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miguel A Ramirez, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Occidente de Kennedy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Occidente de Kennedy</name>
      <address>
        <city>Bogota</city>
        <state>Cundinamarca</state>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Colombia</country>
  </location_countries>
  <link>
    <url>http://www.hospitaloccidentekennedy.gov.co/</url>
    <description>Web Page hospital</description>
  </link>
  <reference>
    <citation>Pang KH, Bate GR, Darvall KA, Adam DJ, Bradbury AW. Healing and recurrence rates following ultrasound-guided foam sclerotherapy of superficial venous reflux in patients with chronic venous ulceration. Eur J Vasc Endovasc Surg. 2010 Dec;40(6):790-5. doi: 10.1016/j.ejvs.2010.08.011. Epub 2010 Sep 27.</citation>
    <PMID>20875753</PMID>
  </reference>
  <reference>
    <citation>Darvall KA, Bate GR, Adam DJ, Silverman SH, Bradbury AW. Ultrasound-guided foam sclerotherapy for the treatment of chronic venous ulceration: a preliminary study. Eur J Vasc Endovasc Surg. 2009 Dec;38(6):764-9. doi: 10.1016/j.ejvs.2009.05.027. Epub 2009 Jul 18.</citation>
    <PMID>19616975</PMID>
  </reference>
  <verification_date>September 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 18, 2011</study_first_submitted>
  <study_first_submitted_qc>May 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 9, 2012</study_first_posted>
  <last_update_submitted>September 30, 2012</last_update_submitted>
  <last_update_submitted_qc>September 30, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 2, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Occidente de Kennedy</investigator_affiliation>
    <investigator_full_name>ernesto nieves</investigator_full_name>
    <investigator_title>medical doctor</investigator_title>
  </responsible_party>
  <keyword>Ultrasound-guided foam sclerotherapy; chronic venous ulcers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Varicose Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

